Eltrombopag Olamine Tablets 25 mg are oral prescription medicines belonging to a class of drugs called thrombopoietin receptor agonists. They act on the thrombopoietin receptor to stimulate the production of platelets, which are blood components that help the body form clots and control bleeding.
Depending on the approved product information and clinical indication, eltrombopag may be prescribed for adults or children with persistent or chronic immune thrombocytopenia (ITP), certain cases of severe aplastic anaemia, or thrombocytopenia associated with chronic hepatitis C treatment. The approved uses may vary by country and product. The medicine is not suitable for every patient with a low platelet count and should be used only under specialist supervision.
Treatment aims to achieve an appropriate platelet count and reduce the risk of bleeding. It does not cure every underlying cause of thrombocytopenia, and platelet counts may fall again after treatment is discontinued.
Possible adverse effects include nausea, diarrhoea, headache, fatigue, and changes in liver enzyme levels. Important risks include liver injury, excessive platelet counts, and blood clots. Regular blood counts and liver function tests are therefore essential.
कैसे उपयोग करें
Follow your specialist's prescription: Take the exact dose and frequency prescribed. Never increase or reduce the dose independently, because excessive platelet counts may increase the risk of blood clots.
Take the tablet consistently: Follow the product instructions regarding the time of administration. Swallow the tablet whole with water. Do not crush, chew, or split it unless the specific product instructions explicitly permit this.
Observe food restrictions: Eltrombopag tablets should generally be taken without food or with a meal containing little calcium. Follow the instructions for your specific product.
Separate calcium and mineral products: Take eltrombopag at least 2 hours before or 4 hours after calcium-rich foods, dairy products, antacids, and supplements containing calcium, iron, magnesium, aluminium, zinc, or other polyvalent cations. These products can reduce absorption. Follow your pharmacist's advice about scheduling.
Attend regular blood tests: Your doctor will monitor platelet counts and liver function before and during treatment. The dose may be adjusted according to the results.
Tell your doctor about other medicines: Report all prescription medicines, over-the-counter products, and supplements. Some medicines may affect eltrombopag levels or increase treatment risks.
Discuss liver disease: Inform your doctor if you have liver problems or a history of blood clots. Additional precautions or dose adjustments may be necessary.
Handle missed doses carefully: Follow the patient leaflet or contact your pharmacist for advice. Do not take an extra dose to compensate for a missed tablet.
Do not stop treatment independently: Stopping eltrombopag may cause platelet counts to fall again. Your specialist may recommend additional blood tests after treatment ends.
Recognise warning signs: Seek urgent medical attention for chest pain, sudden breathlessness, one-sided leg swelling, severe abdominal pain, unusual bleeding, or yellowing of the skin or eyes.
Store the medicine safely: Keep the tablets in their original packaging and follow the manufacturer's storage instructions. Keep them away from children.
भंडारण
Store in cool and dry place
Important guidance
Safety advice
Check with your doctor
AlcoholConsult your doctor
Consult your doctor before consuming alcohol while taking Eltrombopag Olamine Tablets 25 mg, particularly if you have liver disease or abnormal liver function tests. Alcohol may add to liver-related health concerns. Follow your specialist's advice and avoid excessive alcohol consumption during treatment. Alcohol should never replace or interfere with prescribed monitoring.
PregnancyConsult your doctor
If you are pregnant, planning pregnancy, or suspect that you may be pregnant, inform your haematologist before taking Eltrombopag Olamine Tablets 25 mg. Available information about its safety during pregnancy is limited. Your specialist will assess the potential benefits and risks, consider alternative treatments, and determine whether therapy is appropriate for your individual condition.
BreastfeedingConsult your doctor
Consult your specialist before using Eltrombopag Olamine Tablets 25 mg while breastfeeding. It is not known with certainty whether eltrombopag passes into human breast milk or how it may affect an infant. Product prescribing information advises against breastfeeding during treatment. Discuss the benefits of treatment, the importance of breastfeeding, and appropriate alternatives with your healthcare professional.
DrivingConsult your doctor
Eltrombopag Olamine Tablets 25 mg may cause dizziness, fatigue, or other symptoms in some patients. These effects can interfere with driving or operating machinery. Assess how you respond to treatment before performing activities requiring full concentration. Avoid driving if you feel dizzy, unusually tired, or unwell, and consult your doctor if these symptoms persist.
KidneyConsult your doctor
Inform your doctor if you have kidney disease before taking Eltrombopag Olamine Tablets 25 mg. Your healthcare professional will review your kidney function, other medical conditions, and concurrent medicines when planning treatment. Eltrombopag can also interfere with some creatinine laboratory measurements, so unexpected kidney test results may require confirmation using additional assessments.
LiverConsult your doctor
Eltrombopag Olamine Tablets 25 mg can cause liver-related adverse effects and requires careful monitoring. Inform your doctor about hepatitis, cirrhosis, abnormal liver tests, or any previous liver disease before starting treatment. Liver function should be assessed before and during therapy, and your specialist may modify or discontinue treatment if significant abnormalities develop.
Clinical review pending
This page uses verified catalogue facts and responsible medicine-information rules. It supports awareness and does not replace a doctor's advice.
